Paroxysmal supraventricular tachycardia (PSVT)
Conditions
Brief summary
Efficacy: The percentage of patients converting to SR in the first 15 minutes after administration of etripamil NS. A successful conversion is defined as conversion of PSVT to SR that is maintained for at least 30 seconds.
Detailed description
Time to termination of the PSVT episode and conversion to sinus rhythm (SR), Percentage of patients requiring additional medical intervention treatment for the PSVT episode in the first 15 minutes after study drug administration, Frequency of AEs, Local (administration site) tolerability, Post-dose changes in vital signs (HR and BP)
Interventions
DRUGEtripamil
Sponsors
Milestone Pharmaceuticals Inc.
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy: The percentage of patients converting to SR in the first 15 minutes after administration of etripamil NS. A successful conversion is defined as conversion of PSVT to SR that is maintained for at least 30 seconds. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to termination of the PSVT episode and conversion to sinus rhythm (SR), Percentage of patients requiring additional medical intervention treatment for the PSVT episode in the first 15 minutes after study drug administration, Frequency of AEs, Local (administration site) tolerability, Post-dose changes in vital signs (HR and BP) | — |
Countries
Germany, Netherlands, Spain
Outcome results
None listed